AI FOR R&D
AI-Driven Drug Target Identification in Oncology
How ML models are accelerating the identification of novel therapeutic targets in solid tumors.
20 expert articles exploring how AI, GenAI and Machine Learning are transforming Pharma, Diagnostics and Healthcare.
How ML models are accelerating the identification of novel therapeutic targets in solid tumors.
Generative AI is transforming how sponsors design adaptive clinical trial protocols — reducing timelines and amendments.
Using ML to identify predictive and prognostic biomarkers from multi-omics datasets for companion diagnostics.
How generative AI enables hyper-personalized content for healthcare professional outreach at scale.
ML models forecasting payer decisions and optimizing pricing strategies across fragmented EU markets.
Intelligent ticket routing, predictive incident management, and automated compliance documentation.
ML-driven data harmonization across disparate Life Sciences IT systems for a single source of truth.
How to develop a pragmatic, value-driven AI strategy that aligns with pharma business priorities and regulatory realities.
Establishing AI governance frameworks that satisfy regulators while enabling innovation in pharma.
Adapting GAMP 5 and CSV practices for AI/ML systems in regulated Life Sciences environments.
How AI is transforming the diagnostics industry — from laboratory-based companion diagnostics to real-time digital health monitoring.
How structured IT delivery management ensures large-scale pharma transformation programs stay on track, on budget, and compliant.
AI-assisted planning and risk assessment for migrating GxP-validated systems to the cloud.
Managing complex multi-vendor ecosystems in pharmaceutical IT programs without losing accountability or velocity.
What makes project management in pharma IT different — and how to get it right for GxP and non-GxP initiatives.
Combining the rigor of traditional PM with agile flexibility — tailored for GxP-regulated systems delivery.
Orchestrating multi-project transformation programs that deliver strategic outcomes, not just project outputs.
Governance structures that enable fast decisions while maintaining accountability and compliance in regulated environments.
How pharma companies are adopting Agile and Scaled Agile (SAFe) while maintaining GxP compliance — lessons from real transformations.
Practical patterns for running agile sprints on GxP-regulated systems without sacrificing speed or compliance.